Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering
Biomolecules · 2025
DOI: 10.3390/biom15050606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Olga Bednova und 9 weiteren Autor:innen. Beteiligte Einrichtung: Département de Médecine Nucléaire et Radiobiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1H 5N4…. Hauptthemen laut MEDLINE: Trastuzumab, Single-Chain Antibodies, Protein Engineering, Immunoglobulin Fc Fragments. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research (CIHR).
Abstract (Originalsprache)
Antibody-based agents have become a preferred treatment for various diseases, including cancer, due to significant advances in antibody engineering. The use of single-chain Fv-Fcs (scFv-Fcs) has been a promising engineering approach for therapeutic design. The concept is that the Fc provides increased stability and target binding and ultimately improves performance. However, the structural and dynamic relationship between the variable and Fc domains, which are fused in close proximity, and the impact on stability and target binding are not well understood. This study evaluated trastuzumab-derived scFv-Fc antibodies, focusing on the impact of their design on important biopharmaceutical parameters. Computational modelling and molecular dynamics, alongside experimental studies, were used to ascertain their dynamics, expression and purification, stabilities, and binding potencies. The results showed that the scFv subunits exhibited stochastic interplays that lead to diverse shapes and were associated with functional performance. This new understanding of scFv-Fc antibodies and their structural and functional nuances provides important details to further guide the design of more effective and less toxic therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Département de Médecine Nucléaire et Radiobiologie, Faculté de Médecine et des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC J1H 5N4, Canada.
- Faculté de Pharmacie, Université Laval, Québec, QC G1V 0A6, Canada.
- Axe Oncologie, Centre de Recherche du CHU de Québec-Université Laval, Québec, QC G1J 5B3, Canada.
- Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
- Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.
- Laboratory of Molecular Oncology, Biomedicum, University of Helsinki, 00290 Helsinki, Finland.
ORCID-Profile: Olga Bednova, Jessica Pougoue Ketchemen, Mark Barok, Heikki Joensuu, Natalie Zeytuni, Leon Sanche, Jeffrey Victor Leyton
Förderung
- Canadian Institutes of Health Research (CIHR)
Zitieren
APA
Bednova, O., Pougoue Ketchemen, J., Mslati, H., Barok, M., Joensuu, H., Zeytuni, N., Gentile, F., Sanche, L., Fonge, H., & Leyton, J. V. (2025). Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering. Biomolecules. https://doi.org/10.3390/biom15050606
Vancouver
Bednova O, Pougoue Ketchemen J, Mslati H, Barok M, Joensuu H, Zeytuni N, et al. Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering. Biomolecules. 2025. doi:10.3390/biom15050606
BibTeX
@article{Bednova2025,
author = {Bednova, Olga and Pougoue Ketchemen, Jessica and Mslati, Hazem and Barok, Mark and Joensuu, Heikki and Zeytuni, Natalie and Gentile, Francesco and Sanche, Leon and Fonge, Humphrey and Leyton, Jeffrey Victor},
title = {Integrating Biochemical and Computational Approaches Reveal Structural Insights in Trastuzumab scFv-Fc Antibody Engineering},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15050606}
}
EUVIMED